Searched for
BAUSCH HEALTH COMPANIES
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...- Hantavirus scare: Evacuations planned as suspected outbreak traps 150 on ship off Cape VerdeMedics are working to evacuate two individuals with hantavirus symptoms from a luxury cruise ship off West Africa after an outbreak claimed...
- Alembic Pharma gets USFDA nod to market generic anti-fungal solutionThe company has received final approval from the US Food & Drug Administration (USFDA) for Efinaconazole Topical Solution (10 per cent).
- Alembic gets USFDA nod for generic drug for skin conditionAlembic Pharmaceuticals has secured USFDA approval for its generic Tretinoin Cream USP (0.025%), a treatment for acne vulgaris. This ANDA i...
- Canada's TSX hits record high as investors assess economic dataCanada's main stock index inched up to an all-time high on Friday, but losses in heavyweight mining shares kept gains in check, while inves...
- After share surge, contact lens maker Bausch + Lomb says it is exploring saleBausch + Lomb also said its statement was in response to a request from the Canadian Investment Regulatory Organization (CIRO) after a seri...
- TPG, Blackstone bid for Bausch + Lomb in potential $14 billion dealTPG and Blackstone are teaming up to bid for Bausch + Lomb, with an expected valuation between $13 billion and $14 billion. This sale, mana...
- Alembic Pharma gets USFDA nod for generic Bromfenac ophthalmic solutionAlembic Pharmaceuticals Ltd has obtained final approval from the US FDA for its generic Bromfenac ophthalmic solution, used to treat postop...
- OmniActive scouts for acquisitions to expand product portfolio, reachFollowing TA Associates' majority stake acquisition in January 2021, OmniActive aims for accelerated growth through new product launches an...
- Lupin gets USFDA nod for Bromfenac Ophthalmic SolutionPharma major Lupin on Wednesday said it has received approval from the US health regulator to market its generic Bromfenac Ophthalmic Solut...
- Lupin rises over 3% as Brazil subsidiary acquires 9 brands from Bausch HealthThe acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their relia...
- Lupin's Brazil subsidiary acquires 9 brands from Bausch HealthAs part of the transaction, MedQuímica will acquire rights to nine products including Limbitrol, Melleril and Dalmadorm for Central Nervous...
- Granules India gets USFDA nod for generic antidepressant drug"We are pleased to receive approval of Bupropion Hydrochloride (XL) tablet product within first review cycle of 10 months from filing date....
- Granules gets American drug regulator's nod for diabetes management drug MetforminThe US Food and Drug Administration (USFDA) has granted final approval for the company's abbreviated new drug application (ANDA) for Metfor...
- Lupin gets tentative nod from USFDA for its toenail fungus treatment topical solutionThe company has received tentative approval to market its Efinaconazole topical solution, 10%, from the United States Food and Drug Adminis...
- Strides receives USFDA approval for Ethacrynic Acid TabletsStrides Pharma Science announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has received approv...
- Dr Reddy's launches Wilson's disease and cystinuria treatment capsules in USAccording to IQVIA Health data, the Cuprimine brand and generic market had US sales of approximately USD 80 million MAT for the most recent...
- Strides receives USFDA approval for Flucytosine CapsulesThe product is a generic version of Ancobon Capsules, 250 mg and 500 mg, of Bausch Health US, LLC, the Bengaluru- headquartered pharmaceuti...
- Bausch + Lomb mulls strengthening surgical business portfolioThe recent acquisition of Synergetics USA, Inc will provide additional impetus to the firm's portfolio expansion plans in the country, it s...
- Bausch + Lomb eyeing expansion to 800 townsVision care company Bausch + Lomb, a part of the health and wellness firm, Valeant Pharmaceuticals International is looking to expand its p...
Load More
